USANA HEALTH SCIENCES INC's ticker is USNA and the CUSIP is 90328M107. A total of 199 filers reported holding USANA HEALTH SCIENCES INC in Q3 2018. The put-call ratio across all filers is 1.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $32,010 | -9.5% | 660 | 0.0% | 0.00% | -50.0% |
Q4 2023 | $35,376 | -8.5% | 660 | 0.0% | 0.00% | 0.0% |
Q3 2023 | $38,683 | -7.0% | 660 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $41,606 | +0.2% | 660 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $41,514 | +18.2% | 660 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $35,112 | -5.1% | 660 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $36,993 | -22.5% | 660 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $47,758 | -25.8% | 660 | -18.5% | 0.00% | 0.0% |
Q1 2022 | $64,355 | -81.1% | 810 | -76.0% | 0.00% | -60.0% |
Q4 2021 | $341,145 | +9.8% | 3,371 | 0.0% | 0.01% | 0.0% |
Q3 2021 | $310,806 | -10.0% | 3,371 | 0.0% | 0.01% | 0.0% |
Q2 2021 | $345,292 | +9.8% | 3,371 | +4.6% | 0.01% | 0.0% |
Q1 2021 | $314,467 | +26.6% | 3,222 | 0.0% | 0.01% | +25.0% |
Q4 2020 | $248,416 | +4.7% | 3,222 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $237,300 | -18.5% | 3,222 | -18.7% | 0.00% | -20.0% |
Q2 2020 | $291,077 | +27.1% | 3,964 | 0.0% | 0.01% | 0.0% |
Q1 2020 | $228,961 | -26.5% | 3,964 | 0.0% | 0.01% | 0.0% |
Q4 2019 | $311,372 | -6.6% | 3,964 | -18.7% | 0.01% | -16.7% |
Q3 2019 | $333,470 | +3.4% | 4,876 | +20.0% | 0.01% | +20.0% |
Q2 2019 | $322,645 | -5.3% | 4,062 | 0.0% | 0.01% | -16.7% |
Q1 2019 | $340,680 | -28.8% | 4,062 | 0.0% | 0.01% | -40.0% |
Q4 2018 | $478,219 | -11.5% | 4,062 | -9.4% | 0.01% | 0.0% |
Q3 2018 | $540,305 | -99.9% | 4,482 | 0.0% | 0.01% | +25.0% |
Q2 2018 | $516,775,000 | +55.9% | 4,482 | +16.1% | 0.01% | +60.0% |
Q1 2018 | $331,488,000 | +121324.2% | 3,859 | +4.5% | 0.01% | +25.0% |
Q4 2017 | $273,000 | -41.4% | 3,692 | -54.3% | 0.00% | +33.3% |
Q3 2017 | $466,000 | -9.9% | 8,070 | 0.0% | 0.00% | -25.0% |
Q2 2017 | $517,000 | +11.2% | 8,070 | 0.0% | 0.00% | +33.3% |
Q1 2017 | $465,000 | -5.9% | 8,070 | 0.0% | 0.00% | -25.0% |
Q4 2016 | $494,000 | -11.5% | 8,070 | +100.0% | 0.00% | 0.0% |
Q3 2016 | $558,000 | +24.0% | 4,035 | 0.0% | 0.00% | +33.3% |
Q2 2016 | $450,000 | -8.2% | 4,035 | 0.0% | 0.00% | -25.0% |
Q1 2016 | $490,000 | -4.9% | 4,035 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $515,000 | -4.8% | 4,035 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $541,000 | -6.2% | 4,035 | -4.5% | 0.00% | 0.0% |
Q2 2015 | $577,000 | +15.9% | 4,225 | -5.7% | 0.00% | 0.0% |
Q1 2015 | $498,000 | +8.3% | 4,482 | 0.0% | 0.00% | +33.3% |
Q4 2014 | $460,000 | +39.4% | 4,482 | 0.0% | 0.00% | +50.0% |
Q3 2014 | $330,000 | -5.7% | 4,482 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $350,000 | +1.4% | 4,482 | -2.2% | 0.00% | 0.0% |
Q1 2014 | $345,000 | -0.3% | 4,583 | +0.2% | 0.00% | 0.0% |
Q4 2013 | $346,000 | -12.8% | 4,572 | 0.0% | 0.00% | -33.3% |
Q3 2013 | $397,000 | +21.4% | 4,572 | +1.2% | 0.00% | 0.0% |
Q2 2013 | $327,000 | – | 4,517 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Euclidean Technologies Management, LLC | 42,276 | $3,195,000 | 2.92% |
Capital Impact Advisors, LLC | 21,373 | $1,615,000 | 1.30% |
Matarin Capital Management, LLC | 18,266 | $1,381,000 | 0.85% |
ALGERT GLOBAL LLC | 25,440 | $1,923,000 | 0.51% |
Phocas Financial Corp. | 125,970 | $10,231,000 | 0.48% |
Camarda Financial Advisors, LLC | 6,918 | $523,000 | 0.43% |
Wolf Group Capital Advisors | 6,645 | $502,000 | 0.40% |
Spark Investment Management LLC | 27,100 | $2,048,000 | 0.36% |
CLARK ESTATES INC/NY | 32,059 | $2,423,000 | 0.34% |
JAMES INVESTMENT RESEARCH, INC. | 118,515 | $8,957,000 | 0.28% |